Insider · CIK 0001852752
Marvin Johnson
Files at MRNS (MARINUS PHARMACEUTICALS, INC.). First filing Jan 23, 2025, latest Jan 23, 2025.
In brief
Marvin Johnson files SEC Form 4 as director at MRNS (MARINUS PHARMACEUTICALS, INC.). Since Jan 23, 2025, Marvin Johnson has reported 0 open-market buys worth $0 and 1 open-market sell worth $869, the latest filed on Jan 23, 2025.
A track record needs three past buys with six months of prices behind them; Marvin Johnson has 0, so none is measured yet.
The newest scored trade: sold $869 of MRNS on Jan 21, 2025, filed Jan 23, 2025, scored 8 (weak), under a 10b5-1 plan.
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 8Weak | MARINUS PHARMACEUTICALS, INC. | $869 1,610 shares | -11% | - |
Transactions
Every row this insider has filed, 6 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Feb 7, 2025 | MRNS MARINUS PHARMACEUTICALS, INC. | DDisposition to issuer Common Stock | -5,389 | $0.55 | $2,964 | 7,101 | Feb 11, 2025 |
| Feb 11, 2025 | MRNS MARINUS PHARMACEUTICALS, INC. | DDisposition to issuer Common Stock | -7,101 | $0.55 | $3,906 | 0 | Feb 11, 2025 |
| Feb 11, 2025 | MRNS MARINUS PHARMACEUTICALS, INC. | DDisposition to issuer Stock Option (Right to Buy)derivative | -10,450 | $0.00 | $0 | 0 | Feb 11, 2025 |
| Feb 11, 2025 | MRNS MARINUS PHARMACEUTICALS, INC. | DDisposition to issuer Stock Option (Right to Buy)derivative | -20,900 | $0.00 | $0 | 0 | Feb 11, 2025 |
| Feb 11, 2025 | MRNS MARINUS PHARMACEUTICALS, INC. | DDisposition to issuer Stock Option (Right to Buy)derivative | -32,400 | $0.00 | $0 | 0 | Feb 11, 2025 |
| Jan 21, 2025 | MRNS MARINUS PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -1,610 | $0.54 | $869 | 12,490 | Jan 23, 2025 |
Questions about Marvin Johnson
Answered from the filings on this page, as of the latest one.
Is Marvin Johnson buying or selling?
Not in the last 12 months. Marvin Johnson's latest open-market trade on SEC Form 4 was sold $869 of MRNS on Jan 21, 2025.
How did Marvin Johnson's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Marvin Johnson has 0.
Where does Marvin Johnson file Form 4?
Marvin Johnson has filed Form 4 at MRNS (MARINUS PHARMACEUTICALS, INC.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.